Semaglutide for weight control in teens with craniopharyngioma
Part of Cancer, Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests if a weekly injection of semaglutide can help reduce weight in teenagers who have gained weight due to a brain tumor called craniopharyngioma. The study compares semaglutide with a placebo (inactive treatment) to see if it improves weight control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 17 years old.
- You have been treated for craniopharyngioma (a type of brain tumor) and it has been stable for at least 6 months after surgery or radiation.
- You are overweight or obese, or you have gained a lot of weight in the last 6 to 12 months.
- You have tried diet and exercise guidance for at least 6 months without being able to control your weight.
- You are not currently taking other weight loss medications.
- You do not have a history of diabetes, pancreatitis, or certain other serious conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether semaglutide (a once-weekly injection) helps adolescents with a specific genetic form of obesity lose weight. It is for teens who are already being prescribed semaglutide as part of their regular care.
This study tests a weight loss program that combines a weekly medicine injection with lifestyle coaching for teens with obesity. It aims to help teens achieve a healthier weight and improve overall wellness.
This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.
This trial tests if restarting semaglutide (a weekly injection for weight loss) soon after sleeve gastrectomy helps teens with severe obesity keep losing weight. It is for patients who were already taking semaglutide before their surgery.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.
Hear when a new Craniopharyngioma, Child trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.